Estradiol Stimulates Vascular Endothelial Growth Factor and Interleukin-6 in Human Lactotroph and Lactosomatotroph Pituitary Adenomas

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 1, 2004, Pages 18-23

  Onofri, C ^a   Carbia Nagashima, A ^b   Schaaf, L ^a   Feirer, M ^a   Lohrer, P ^a   Stummer, W ^c   Berner, S ^d   Chervin, A ^d   Goldberg, V ^e   Stalla, G K ^a   Renner, Ulrich ^a   Arzt, E ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTO DE FISIOLOGÍA   (Argentina)

^c UNIVERSITY OF MUNICH   (Germany)

^d Hospital Oftalmologico Santa Lucia   (Argentina)

^e INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Estrogens; Interleukin 6; Lactotroph lactosomatotroph adenomas; Vascular endothelial growth factor

Indexed keywords

ESTRADIOL; INTERLEUKIN 6; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 10744230664     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815722     Document Type: Article

References (45)

1. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK. Interleukin involvement in anterior pituitary cell growth regulation: effects of interleukin-2 and interleukin-6. Endocrinology 1993; 132: 459-467
2. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998; 19: 798-827
3. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nature Rev 2002; 2: 836-849
4. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 1997; 18: 1155-1161
5. Banerjee SK, Zoubine MN, Sarkar DK, Weston AP, Shah JH, Campbell DR. 2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: possible role of vascular endothelial growth factor. Anticancer Res 2000a; 20: 2641-2646
6. Banerjee SK, Zoubine MN, Tran TM, Weston AP, Campbell DR. Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int J Oncol 2000 b; 16: 253-260
7. Borgundvaag B, Kudlow JE, Mueller SG, George SR. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-alpha gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 1992; 130: 3453-3458
8. Carbia Nagashima A, Giacomini D, Perez Castro C, Paez Pereda M, Renner U, Stalla GK, Arzt E. Transcriptional regulation of interleukin-6 in pituitary folliculo-stellate cells. Mol Cell Endocrinol 2003; 201: 47-56
9. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395
10. Cracchiolo D, Swick JM, McKiernan L, Sloan E, Raina S, Sloan C, Wendell DL. Estrogen-dependent growth of a rat pituitary tumor involves, but does not require, a high level of vascular endothelial growth factor. Exp Biol Med (Maywood) 2002; 277: 494-499
11. Deshpande R, Khalili H, Pergolizzi RG, Michael S, Chang MY. Estradiol down-regulates LPS-induced cytokine production and NFkappaB activation in murine macrophages. Am J Reprod Immunol 1997; 38: 46-54
12. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25
13. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-858
14. Galien R, Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res 1997; 25: 2424-2429
15. Gordon CM, LeBoff MS, Glowacki J. Adrenal and gonadal steroids inhibit IL-6 secretion by human bone marrow cells. Cytokine 2001; 16: 178-186
16. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276: 36869-36872
17. Heaney AP, Fernando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 2002; 109: 277-283
18. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999; 5: 1317-1321
19. Hentges S, De A, Pastorcic M, Boyadjieva N, Sarkar DK. Opposing actions of two TGF-β isoforms on pituitary lactotropic cell proliferation. Endocrinology 2000; 141: 1528-1535
20. Hentges S, Sarkar DK. Transforming growth factor-β regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 2001; 22: 340-363
21. Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A, Kendall-Taylor P, Weetman AP. Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Metab 1994; 78: 180-187
22. Jones TH, Justice S, Price A, Chapman K. Interleukin-6 secreting human pituitary adenomas in vitro. J Clin Endocrinol Metab 1991; 73: 207-209
23. Kim MS, Chae HJ, Shin TY, Kim HM, Kim HR. Estrogen regulates cytokine release in human mast cells. Immunopharmacol Immunotoxicol 2001; 23: 495-504
24. Kovacs K, Stefaneanu L, Ezzat S, Smyth HS. Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphological study. Arch Pathol Lab Med 1994; 118: 562-565
25. Lohrer P, Gloddek J, Carbia Nagashima A, Korali Z, Hopfner U, Paez Pereda M, Arzt E, Stalla GK, Renner U. Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-κB pathway. Endocrinology 2000; 141: 4457-4465
26. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 2001; 74: 95-105
27. McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE. Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 1995; 136: 4479-4488
28. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA Gittoes NJL. Vascular endothelial growth actor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 2002; 87: 4238-4244
29. Nayak NR, Brenner R. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab 2002; 87: 1845-1855
30. Newton CJ, Arzt E, Stalla GK. Involvement of the estrogen receptor in the growth response of pituitary tumor cells to interleukin-2. Biochem Biophys Res Commun 1994; 205: 1930-1937
31. Ochoa AL, Mitchner NA, Paynter CD, Morris RE, Ben-Jonathan N. Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen. J Endocrinol 2000; 165: 483-492
32. Paez-Pereda M, Giacomini D, Refojo D, Carbia Nagashima A, Hopfner U, Grübler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E. Involvement of bone morphogenetic protein 4 (BMP-4) in prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 2003; 100: 1034-1039
33. Paez Pereda M, Goldberg V, Chervin A, Carrizo G, Molina A, Andada J, Sauer J, Renner U, Stalla GK, Arzt E. Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants. Mol Cell Endocrinol 1996; 124: 33-42
34. Paez Pereda M, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervin A, Berner S, Molina H, Stalla GK, Renner U, Arzt E. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Exp Clin Endocrinol Diabetes 2000; 108: 202-207
35. Perillo B, Sasso A, Abbondanza C, Palumbo G. 17 beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 2000; 20: 2890-2901
36. Rachon D, Mysliwska J, Suchecka-Rachon K, Wieckiewicz J, Mysliwski A. Effect of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women. J Endocrinol 2002; 172: 387-395
37. Renner U, Arzberger T, Pagotto U, Leimgruber S, Uhl E, Müller A, Lange M, Weindl A, Stalla GK. Heterogenous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1998; 83: 1368-1375
38. Renner U, Gloddek J, Arzt E, Inoue K, Stalla GK. Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells. Exp Clin Endocrinol Diabetes 1997; 105: 345-352
39. Sawada T, Koike K, Kanda Y, Ikesami H, Jikihara T, Maeda T, Osako Y, Hirota K, Miyake A. IL-6 stimulates cell proliferation of rat anterior pituitary clonal cell lines in vitro. J Endocrinol Invest 1995; 18: 83-90
40. Seyd V, Ulinski G, Mok SC, Ho SM. Reproductive hormone-induced, STAT3-mediated interleukin-6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst 2002; 94: 617-629
41. Sugino N, Kashida S, Takiguchi S, Karube-Harada A, Kato H. Expression of vascular endothelial growth factor (VEGF) receptors in rat corpus luteum: regulation by oestradiol during mid-pregnancy. Reproduction 2001; 122: 875-881
42. Takei H, Lee ES, Jordan VC. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer. Breast Cancer 2002; 9: 39-42
43. Ueta Y, Levy A, Chowdrey HS, Lightman SL. S-100 antigen-positive folliculostellate cells are not the source of IL-6 gene expression in human pituitary adenomas. J Neuroendocrinol 1995; 7: 467-474
44. Vankelecom H, Matthys P, Van Damme J, Heremans H, Billiau A, Denef C. Immunocytochemical evidence that S-100 positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity. J Histochem Cytochem 1993; 41: 151-156
45. Wang LH, Yang XY, Mihalic K, Xiao W, Li D, Farrar WL. Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3. J Biol Chem 2001; 276: 31839-31844